SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India rises on reporting 39% rise in Q4 net profit

18 May 2022 Evaluate

Abbott India is currently trading at Rs. 17701.00, up by 65.30 points or 0.37% from its previous closing of Rs. 17635.70 on the BSE.

The scrip opened at Rs. 17543.00 and has touched a high and low of Rs. 17949.00 and Rs. 17450.10 respectively. So far 348 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 23902.30 on 05-Oct-2021 and a 52 week low of Rs. 15525.00 on 07-Feb-2022.

Last one week high and low of the scrip stood at Rs. 17949.00 and Rs. 16202.80 respectively. The current market cap of the company is Rs. 37666.73 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 7.74% and 17.27% respectively.

Abbott India has reported a rise of 38.66% in its net profit at Rs 211.41 crore for the quarter ended March 31, 2022 as compared to Rs 152.47 crore for the same quarter in the previous year. Total income of the company increased by 14.47% at Rs 1,276.07 crore for Q4FY22 as compared Rs 1,114.74 crore for the corresponding quarter previous year.

For the year ended March 31, 2022, the company has reported a rise of 15.64% in its net profit at Rs 798.70 crore as compared to Rs 690.69 crore for the previous year. Total income of the company increased by 13.79% at Rs 4,996.48 crore for year under review as compared to Rs 4,390.92 crore for year ended March 31, 2021.


Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×